Bladder News and Research

RSS

Lower urinary tract symptoms associated with mortality risk in older men

For men in their fifties and older, moderate to severe lower urinary tract symptoms (LUTS) such as incontinence and frequent nighttime urination (nocturia) are associated with an increased risk of death during long-term follow-up, suggests a Finnish study in The Journal of Urology, an Official Journal of the American Urological Association.

27 Apr 2022

New type of silver coating prevents bacteria from adhering to medical implants

According to folklore, silver bullets kill werewolves, but in the real world, researchers want to harness this metal to fight another deadly foe: bacteria.

27 Apr 2022

CDC issues health alert about children identified with hepatitis and adenovirus infection

CDC today issued a nationwide health alert to notify clinicians and public health authorities about a cluster of children identified with hepatitis and adenovirus infection – and to ask all physicians to be on the lookout for symptoms and to report any suspected cases of hepatitis of unknown origin to their local and state health departments.

26 Apr 2022

AI-based system improves bladder cancer treatment response assessment

In a small but multi-institutional study, an artificial intelligence-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder removal surgery).

22 Apr 2022

Cells’ exosomes can be effective vehicles for delivering cancer treatments to tumors

A new study published in Cancer Medicine indicates that exosomes, or small bubbles that transport molecules from one cell to another, can be effective vehicles for delivering cancer treatments to tumors.

20 Apr 2022

Breakthrough finding reveals how male sex hormones contribute to cancer-related sex bias

Patients with cancers stemming from non-reproductive organs, such as bladder and liver cancer, have striking discrepancies in incidence, progression, response to treatment and survival outcomes depending on their sex. In almost all cases, male patients have worse prognoses and outcomes.

15 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

Dog owners' feeding habits and the impact of FDA hygiene protocols on dog food dish contamination

A survey has recently been conducted by the North Carolina State University, USA, to evaluate the pet food and dish handling habits of pet owners and their impact on bacterial contamination.

12 Apr 2022

Drug used to treat lung cancer could help improve survival rates for bladder cancer patients

Scientists from the University of Sheffield have discovered a drug already used to treat lung cancer could help to improve survival rates for bladder cancer patients.

11 Apr 2022

Study identifies several therapeutically effective drugs for bladder cancer

Hundreds of chemical compounds were screened on cell cultures representing different stages and subtypes of bladder cancer and several promising agents with inhibitory (growth-inhibiting) effects were identified.

11 Apr 2022

Cancer risk and related mortality significantly higher among patients with kidney disease

Patients with kidney disease may have an increased risk of cancer and may be more likely to die from cancer.

8 Apr 2022

New ML models show high accuracy in predicting complications after abdominal hernia repair

Machine learning (ML) models developed by surgeons at the University of Texas MD Anderson Cancer Center in Houston have shown a high level of accuracy in predicting which types of patients are most likely to have a hernia recurrence or other complications.

7 Apr 2022

Study provides new insights into cause of metastasis in prostate cancer

Prostate cancers remain localized in the majority of cases, giving affected individuals a good chance of survival.

4 Apr 2022

Vitamin C may help to counteract common side effect of the chemotherapy drug

A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin.

4 Apr 2022

Domestic violence survivor, UK patient stands and walks for the first time in more than eight years

"Deep breaths, April. Deep breaths." April Ballentine nods, steeling herself. As she sits inside the lab of the University of Kentucky's Sports Medicine Research Institute (SMRI), her anticipation stirs up an incredible amount of pure nervousness.

1 Apr 2022

Aromatic amines in pets' stool could be a sign of health issues for humans

Dogs and cats may be exposed in their homes to a potentially toxic group of chemicals, with their discovery in the pets' stool being a sign of health issues for humans living with them, a new study shows.

31 Mar 2022

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.

28 Mar 2022

Comprehensive preventive efforts cut the number of catheter infections

Patients with urinary catheters often get infections. But more comprehensive preventive efforts in health care cut the proportion affected in a group of frail elderly patients from 18 to 4 percent, a study led by University of Gothenburg researchers shows.

28 Mar 2022

30-60 minutes/week of muscle strengthening activities may lower mortality risk

Between 30 and 60 minutes of muscle strengthening activity every week is linked to a 10-20% lower risk of death from all causes, and from cardiovascular disease, diabetes, and cancer, in particular, finds a pooled data analysis of the available evidence, published online in the British Journal of Sports Medicine.

1 Mar 2022

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at the 2022 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (GU ASCO) on February 18, 2022.

15 Feb 2022